IL146471A0 - Orally active a1 adenosine receptor agonists - Google Patents

Orally active a1 adenosine receptor agonists

Info

Publication number
IL146471A0
IL146471A0 IL14647100A IL14647100A IL146471A0 IL 146471 A0 IL146471 A0 IL 146471A0 IL 14647100 A IL14647100 A IL 14647100A IL 14647100 A IL14647100 A IL 14647100A IL 146471 A0 IL146471 A0 IL 146471A0
Authority
IL
Israel
Prior art keywords
receptor agonists
adenosine receptor
orally active
orally
active
Prior art date
Application number
IL14647100A
Other languages
English (en)
Original Assignee
Cv Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cv Therapeutics Inc filed Critical Cv Therapeutics Inc
Publication of IL146471A0 publication Critical patent/IL146471A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
IL14647100A 1999-05-24 2000-05-19 Orally active a1 adenosine receptor agonists IL146471A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/317,523 US6576619B2 (en) 1999-05-24 1999-05-24 Orally active A1 adenosine receptor agonists
PCT/US2000/014036 WO2000071558A1 (en) 1999-05-24 2000-05-19 Orally active a1 adenosine receptor agonists

Publications (1)

Publication Number Publication Date
IL146471A0 true IL146471A0 (en) 2002-07-25

Family

ID=23234062

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14647100A IL146471A0 (en) 1999-05-24 2000-05-19 Orally active a1 adenosine receptor agonists
IL146471A IL146471A (en) 1999-05-24 2001-11-13 Agonists N - Oxulan - 3 - Il 2 ', 3', 5 ', (O - Transformed) Adenosine A1 adenosine receptors active in the mouth, pharmacists containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL146471A IL146471A (en) 1999-05-24 2001-11-13 Agonists N - Oxulan - 3 - Il 2 ', 3', 5 ', (O - Transformed) Adenosine A1 adenosine receptors active in the mouth, pharmacists containing them

Country Status (19)

Country Link
US (1) US6576619B2 (zh)
EP (1) EP1181302B1 (zh)
JP (2) JP2003520776A (zh)
KR (1) KR100537032B1 (zh)
CN (1) CN1183153C (zh)
AR (1) AR035909A1 (zh)
AT (1) ATE250621T1 (zh)
AU (1) AU760658B2 (zh)
BR (1) BR0010882A (zh)
CA (1) CA2375040C (zh)
DE (1) DE60005507T2 (zh)
ES (1) ES2206238T3 (zh)
IL (2) IL146471A0 (zh)
MX (1) MXPA01012038A (zh)
NO (1) NO320854B1 (zh)
NZ (1) NZ515580A (zh)
TW (1) TW593330B (zh)
WO (1) WO2000071558A1 (zh)
ZA (1) ZA200109626B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790839B2 (en) 1999-01-07 2004-09-14 Can-Fite Biopharma Ltd. Pharmaceutical administration of adenosine agonists
IL127947A0 (en) 1999-01-07 1999-11-30 Can Fite Technologies Ltd Pharmaceutical use of adenosine agonists
MXPA04008008A (es) * 2002-02-19 2005-03-23 Cv Therapeutics Inc Agonistas parciales y completos de receptores de adenosina a1.
WO2004000280A1 (en) * 2002-04-29 2003-12-31 Shire Laboraties, Inc. Pharmaceutical formulations with improved bioavailability
EP1680110B1 (en) * 2003-11-04 2011-01-05 Supernus Pharmaceuticals, Inc. Once daily dosage forms of trospium
EP1680100A4 (en) 2003-11-04 2012-08-08 Supernus Pharmaceuticals Inc QUATERNARY AMMONIUM COMPOUNDS CONTAINING BIOAVAILABILITY ACTIVATORS
EP2081932A2 (en) 2006-06-27 2009-07-29 BIOVITRUM AB (publ) 2-o'-methyladenosine derivatives and their use as agonists or antagonists of an adenosine receptor
US7731604B2 (en) * 2006-10-31 2010-06-08 Taylor Made Golf Company, Inc. Golf club iron head
CN101712709A (zh) * 2008-10-06 2010-05-26 中国医学科学院药物研究所 三乙酰基-3-羟基苯基腺苷及其调血脂的用途
DE102011005232A1 (de) 2011-03-08 2012-09-13 AristoCon GmbH & Co. KG Adenosin und seine Derivate zur Verwendung in der Schmerztherapie

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460929A1 (de) 1974-12-21 1976-06-24 Boehringer Sohn Ingelheim Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung
US4364922A (en) 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
JPS57171998A (en) * 1981-04-15 1982-10-22 Fujisawa Pharmaceut Co Ltd Adenosine derivative and its salt, preparation thereof and medicinal composition containing the same
DE3138397A1 (de) 1981-09-26 1983-04-07 Hoechst Ag, 6230 Frankfurt "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"
US4593019A (en) 1984-10-26 1986-06-03 Warner-Lambert Company N6 -tricyclic adenosines
CA1255297A (en) 1984-10-26 1989-06-06 Bharat Trivedi N.sup.6-benzopyrano and benzothiopyrano adenosines
WO1988003148A2 (en) 1986-10-31 1988-05-05 Warner-Lambert Company Heteroaromatic derivatives of adenoside
US4954504A (en) 1986-11-14 1990-09-04 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity
EP0355131B1 (en) * 1987-10-28 1996-09-04 Pro-Neuron, Inc. Acyl deoxyribonucleoside derivatives and uses thereof
US4980379A (en) 1988-06-30 1990-12-25 The University Of Virginia Use of adenosine antagonists in the treatment of bradyarrhythmias and hemodynamic depression associated with cardiopulmonary resucitation and/or cardiovascular collapse
DE8817122U1 (de) 1988-12-22 1993-02-04 Boehringer Ingelheim Kg, 55218 Ingelheim Neue Xanthinderivate mit Adenosinantogenistischer Wirkung
KR910700253A (ko) 1989-01-31 1991-03-14 로버트 제이, 바란 N_6-치환-9-메틸아데닌: 신규한 부류의 아데노신 수용체 길항질
US5017578A (en) 1989-06-09 1991-05-21 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents
JPH06102662B2 (ja) 1989-09-01 1994-12-14 協和醗酵工業株式会社 キサンチン誘導体
DE4019892A1 (de) 1990-06-22 1992-01-02 Boehringer Ingelheim Kg Neue xanthinderivate
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US5432164A (en) 1991-10-24 1995-07-11 Novo Nordisk A/S C2,N6 -disubstituted adenosine derivatives
DE4205306B4 (de) 1992-02-21 2005-11-24 Glüsenkamp, Karl-Heinz, Dr. Säureamide, Arzneimittel mit denselben und Verfahren zur Herstellung von Säureamiden
US5288721A (en) 1992-09-22 1994-02-22 Cell Therapeutics, Inc. Substituted epoxyalkyl xanthines
WO1994016702A1 (en) 1993-01-26 1994-08-04 Kyowa Hakko Kogyo Co., Ltd. Remedy for irregular bowel movement
AU7331094A (en) 1993-07-13 1995-02-13 United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The A3 adenosine receptor agonists
US5446046A (en) 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
GB9723590D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
GB9723566D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
NO20015662D0 (no) 2001-11-20
JP2003520776A (ja) 2003-07-08
IL146471A (en) 2007-06-03
ZA200109626B (en) 2004-03-10
NO20015662L (no) 2002-01-23
KR20020092777A (ko) 2002-12-12
EP1181302B1 (en) 2003-09-24
NO320854B1 (no) 2006-02-06
DE60005507D1 (de) 2003-10-30
CA2375040C (en) 2006-02-07
AU760658B2 (en) 2003-05-22
AU5037600A (en) 2000-12-12
AR035909A1 (es) 2004-07-28
ES2206238T3 (es) 2004-05-16
CN1390228A (zh) 2003-01-08
US20020091099A1 (en) 2002-07-11
KR100537032B1 (ko) 2005-12-16
JP2006348040A (ja) 2006-12-28
EP1181302A1 (en) 2002-02-27
US6576619B2 (en) 2003-06-10
DE60005507T2 (de) 2004-06-24
WO2000071558A1 (en) 2000-11-30
CA2375040A1 (en) 2000-11-30
CN1183153C (zh) 2005-01-05
TW593330B (en) 2004-06-21
MXPA01012038A (es) 2002-05-06
ATE250621T1 (de) 2003-10-15
BR0010882A (pt) 2002-06-11
NZ515580A (en) 2004-06-25

Similar Documents

Publication Publication Date Title
IL147198A0 (en) N-pyrazole a2a receptor agonists
IL147195A0 (en) C-pyrazole a2a receptor agonists
IL135966A0 (en) Adenosine a1 receptor agonists
IL135965A0 (en) Adenosine a1 receptor agonists
IL135964A0 (en) Adenosine a1 receptor agonists
HUP0401437A3 (en) Adenosine a3 receptor agonists
AU5203999A (en) Beta3-adrenergic receptor agonists
MXPA02002546A (es) Composiciones farmaceuticas que comprenden un receptor agonista o antagonista de la adenosina.
AU5640299A (en) 4-quinolinemethanol derivatives as purine receptor antagonists.(ii)
PT1192170E (pt) Agonistas de receptor a2a de propargilfenileter
GB9903767D0 (en) Receptor assay
IL146471A0 (en) Orally active a1 adenosine receptor agonists
AU2203801A (en) Formulations of adenosine a1 agonists
HUP0303533A3 (en) Adenosine a1 agonist adenosine derivatives
EP1238278A4 (en) PROCEDURE FOR DETECTING THE QUALITY OF SPERM
AU2203601A (en) Formulations of adenosine a1 agonists
IL127947A0 (en) Pharmaceutical use of adenosine agonists
AU2001247227A1 (en) 2-thioether a2a receptor agonists
AU4980999A (en) A3 adenosine receptor antagonists
AU2204001A (en) Formulations of adenosine a1 agonists
AU2208301A (en) Formulations of adenosine a1 agonists
GB9913180D0 (en) Interleukin-1 receptor associated kinases
GB0010292D0 (en) A adenosine receptor agonists
SI1235787T1 (en) $g(b)2-ADRENERGIC RECEPTOR AGONISTS
PL342404A1 (en) Nucleosides

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed